capital increase, VAVA agrees not to sell the newly issued ordinary shares (Silent Period) which receives from subscription for a period of 1 year from the trading date on the SET. Upon the expiry of the 6
VAVA are no policy to changing the core business of the Company. The Company will continue to operate as usual. 2. VAVA agrees not to sell the newly issued ordinary shares (Silent Period) which receives
the stock price of Demeter Corporation Public Company Limited (“the “Company”) during the recent period. The Company would like to inform that its business operation remains as usual. There is no
announced a measure for temporary liquidity management by allowing asset management companies to borrow or enter into repurchase agreements at the maximum rate of 30 percent, instead of the usual 10 percent
the completeness of the information before distributing to shareholders. In this regard, the revised rules together with the silent period measures prescribed by the Stock Exchange of Thailand are
unit holders.Furthermore, SEC will launch an online submission channel for the convenience of the business providers rather than the usual CD submission, as well as a mean to alleviate burdens and the
สารสนเทศข่าว มติ BOD 5-60 20171204En No. NDR013/2017 Subject Resolution of the Board of Directors’ Meeting To President The Stock Exchange of Thailand Enclosure 1. Information Memorandum on the Acquisition of Assets and the Connected Transaction 2. Information Memorandum regarding the offering of the newly issued ordinary shares to specific investors (Private Placement) 3. Capital Increase Report Form (F53 N.D. Rubber Public Company Limited (“ No.5/2017 held on November 26, 2017 which has the ma...
บังคับของตลาดหลักทรัพย์แห่งประเทศไทยเกี่ยวกับการกำหนดระยะเวลาการห้ามขายหุ้น (silent period) คาดว่าจะช่วยแก้ปัญหา PP ราคาต่ำในลักษณะที่เป็นการเอาเปรียบผู้ถือหุ้นเดิม การเพิ่มทุนที่ไม่มีวัตถุประสงค์ชัดเจน
amended) is less than 15 percent and the total size of transactions in the past 6 months is also less than 15 percent. The transaction is subject to usual regulatory approvals (including approval by the